Viewing Study NCT02389959

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:31 PM
Ignite Modification Date: 2026-02-24 @ 8:50 AM
Study NCT ID: NCT02389959
Status: COMPLETED
Last Update Posted: 2021-09-01
First Post: 2015-03-11
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Intranasal Bevacizumab for HHT-Related Epistaxis
Sponsor: Stanford University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HHT View
None Hereditary Hemorrhagic Telangiectasia View
None Epistaxis View
None Nose Bleeds View
None Nasal Bleeding View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HHT View
None Hereditary Hemorrhagic Telangiectasia View
None epistaxis View
None nose bleeds View
None nasal bleeding View
None Avastin View
None bevacizumab View